GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Holy Stone Healthcare Co Ltd (ROCO:4194) » Definitions » Net Cash per Share

Holy Stone Healthcare Co (ROCO:4194) Net Cash per Share : NT$1.42 (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Holy Stone Healthcare Co Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Holy Stone Healthcare Co's Net Cash per Share for the quarter that ended in Dec. 2024 was NT$1.42.

The historical rank and industry rank for Holy Stone Healthcare Co's Net Cash per Share or its related term are showing as below:

ROCO:4194' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 3.39   Med: 9.6   Max: 27.21
Current: 5

During the past 12 years, the highest Price-to-Net-Cash Ratio of Holy Stone Healthcare Co was 27.21. The lowest was 3.39. And the median was 9.60.

ROCO:4194's Price-to-Net-Cash is ranked worse than
57.3% of 836 companies
in the Biotechnology industry
Industry Median: 3.82 vs ROCO:4194: 5.00

Holy Stone Healthcare Co Net Cash per Share Historical Data

The historical data trend for Holy Stone Healthcare Co's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Holy Stone Healthcare Co Net Cash per Share Chart

Holy Stone Healthcare Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.54 1.05 2.84 -0.25 1.42

Holy Stone Healthcare Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.84 1.93 -0.25 1.80 1.42

Competitive Comparison of Holy Stone Healthcare Co's Net Cash per Share

For the Biotechnology subindustry, Holy Stone Healthcare Co's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Holy Stone Healthcare Co's Price-to-Net-Cash Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Holy Stone Healthcare Co's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Holy Stone Healthcare Co's Price-to-Net-Cash falls into.


;
;

Holy Stone Healthcare Co Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Holy Stone Healthcare Co's Net Cash per Share for the fiscal year that ended in Dec. 2024 is calculated as

Net Cash per Share (A: Dec. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(266.68-58.916-0)/145.974
=1.42

Holy Stone Healthcare Co's Net Cash per Share for the quarter that ended in Dec. 2024 is calculated as

Net Cash per Share (Q: Dec. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(266.68-58.916-0)/145.974
=1.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Holy Stone Healthcare Co  (ROCO:4194) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Holy Stone Healthcare Co Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Holy Stone Healthcare Co's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Holy Stone Healthcare Co Business Description

Traded in Other Exchanges
N/A
Address
Number 88, Section 1, Neihu Road, 4th Floor, Neihu District, Taipei, TWN, 11493
Holy Stone Healthcare Co Ltd is a Taiwan based company focused on a biopolymer drug delivery platform. It is involved in the development of new drugs and medical devices, especially hyaluronic acid related therapeutic products. The products of the company include RenehaVis, SportVis, TRUD, and GAF.

Holy Stone Healthcare Co Headlines

No Headlines